We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Test Could Provide Snapshot of Overall Health

By LabMedica International staff writers
Posted on 09 Jul 2024

Cardiorespiratory fitness significantly influences various bodily systems, from metabolism to brain function. More...

Currently, there is no standardized method to quantitatively assess cardiorespiratory fitness, even though it provides a comprehensive view of a person’s health. Now, a new study has found that levels of circulating proteins could be effective biomarkers for cardiorespiratory fitness, a crucial but previously difficult-to-quantify component of an individual’s overall health.

In the study published in Nature Medicine, investigators at Northwestern University Feinberg School of Medicine (Chicago, IL, USA) used statistical models to identify circulating proteins that most significantly affect overall health across over 14,000 participants. The researchers developed a cardiorespiratory fitness score based on an individual's levels of certain circulating proteins, which are linked to inflammation, neuronal survival and growth, and oxidative stress, among other factors. This scoring system was then validated using data from 20,000 individuals in the UK Biobank, revealing that a favorable score correlates with a lower risk of all-cause mortality.

The team further tested the validity of their scoring system by analyzing the circulating proteins of over 600 individuals before and after they participated in a 20-week exercise program. The study found that improvements in participants' cardiorespiratory fitness scores were associated with the beneficial impacts of exercise on their cardiorespiratory systems. These results establish a foundation for a scoring system that could potentially assess holistic health through a simple blood test, offering insights into the relationship between fitness and health. Building on this, the researchers plan to extend this protein scoring method to additional areas of overall health.

“We know a lot about trajectories of health. Someone might be on a declining trajectory, but when we see patients at one time point, it’s really hard for us to extrapolate what a trajectory of someone’s health may be,” said Ravi Kalhan, MD, MS, professor of Medicine in the Division of Pulmonary and Critical Care, of Preventive Medicine in the Division of Epidemiology, and a co-author of the study. “If we could apply these single-time-point measurements using a blood test that reflects a greater, more difficult-to-ascertain factor of health, that really would be interesting.”

Related Links:
Northwestern University Feinberg School of Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Automated Immunoassay Analyzer
SuperFlex™
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.